ORCID as entered in ROS
![orcid_icon](/themes/resgate8/images/icons/ORCIDiD_icon24x24.png)
Select Publications
2016, 'Health service use and costs in the last 6 months of life in elderly decedents with a history of cancer: a comprehensive analysis from a health payer perspective', British Journal of Cancer, http://dx.doi.org/10.1038/bjc.2016.75
,2016, ''I don't think I'd be frightened if the statins went': A phenomenological qualitative study exploring medicines use in palliative care patients, carers and healthcare professionals.', BMC Palliative Care, 15, pp. 13, http://dx.doi.org/10.1186/s12904-016-0086-7
,2016, 'How does prescribing for antihypertensive products stack up against guideline recommendations? An Australian population-based study (2006–2014)', British Journal of Clinical Pharmacology, 82, pp. 1134 - 1145, http://dx.doi.org/10.1111/bcp.13043
,2016, 'Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated', British Journal of Clinical Pharmacology, pp. 1123 - 1133, http://dx.doi.org/10.1111/bcp.13026
,2016, 'Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims', British Journal of Clinical Pharmacology, pp. 255 - 267, http://dx.doi.org/10.1111/bcp.12937
,2015, 'The Australian Pharmaceutical Benefits Scheme data collection: A practical guide for researchers', BMC Research Notes, 8, pp. 634, http://dx.doi.org/10.1186/s13104-015-1616-8
,2015, 'Looking forward and looking back: The balancing act in new drug user designs for pharmacoepidemiological research', Pharmacoepidemiology and Drug Safety, 24, pp. 1117 - 1119, http://dx.doi.org/10.1002/pds.3848
,2015, 'Older peoples’ attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia', International Journal of Clinical Pharmacy, 37, pp. 949 - 957, http://dx.doi.org/10.1007/s11096-015-0147-7
,2015, 'Prevalence of Potential and Clinically Relevant Statin–Drug Interactions in Frail and Robust Older Inpatients', Drugs and Aging, 32, pp. 849 - 856, http://dx.doi.org/10.1007/s40266-015-0302-9
,2015, 'Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review', PharmacoEconomics, 33, pp. 905 - 924, http://dx.doi.org/10.1007/s40273-015-0293-8
,2015, 'Patterns of care and survival after a cancer of unknown primary (CUP) diagnosis: A population-based nested cohort study in Australian Government Department of Veterans' Affairs clients', Cancer Epidemiology, 39, pp. 578 - 584, http://dx.doi.org/10.1016/j.canep.2015.02.007
,2015, 'Harmonizing post-market surveillance of prescription drug misuse: A systematic review of observational studies using routinely collected data (2000–2013)', Drug Safety, 38, pp. 553 - 564, http://dx.doi.org/10.1007/s40264-015-0294-8
,2015, 'The crux of the matter: Did the ABC’s catalyst program change Statin use in Australia?', Medical Journal of Australia, 202, pp. 591 - 595, http://dx.doi.org/10.5694/mja15.00103
,2015, 'Antidepressant therapy in cancer patients: Initiation and factors associated with treatment', Pharmacoepidemiology and Drug Safety, 24, pp. 600 - 609, http://dx.doi.org/10.1002/pds.3753
,2015, 'Cost of cancer care for patients undergoing chemotherapy: The elements of cancer care study', Asia-Pacific Journal of Clinical Oncology, 11, pp. 178 - 186, http://dx.doi.org/10.1111/ajco.12354
,2015, 'Improving the Legitimacy of Medicines Funding Decisions: A Critical Literature Review', Therapeutic Innovation and Regulatory Science, 49, pp. 364 - 368, http://dx.doi.org/10.1177/2168479015579519
,2015, 'Studies using australia's pharmaceutical benefits scheme data for pharmacoepidemiological research: A systematic review of the published literature (1987-2013)', Pharmacoepidemiology and Drug Safety, 24, pp. 447 - 455, http://dx.doi.org/10.1002/pds.3756
,2015, 'Manual versus automated coding of free-text self-reported medication data in the 45 and Up Study: A validation study', Public Health Research and Practice, 25, http://dx.doi.org/10.17061/phrp2521518
,2015, 'Resource use, costs and quality of end of life care: Observations in a cohort of elderly Australian cancer decedents', Implementation Science, 10, pp. 25, http://dx.doi.org/10.1186/s13012-014-0148-2
,2015, 'The POPPY Research Programme protocol: Investigating opioid utilisation, costs and patterns of extramedical use in Australia', BMJ Open, 5, pp. e007030, http://dx.doi.org/10.1136/bmjopen-2014-007030
,2015, 'Can administrative data be used to measure chemotherapy side effects?', Expert Review of Pharmacoeconomics & Outcomes Research, 15, pp. 215 - 222, http://dx.doi.org/10.1586/14737167.2015.990888
,2015, 'Health service utilisation and investigations before diagnosis of cancer of unknown primary (CUP): A population-based nested case-control study in Australian Government Department of Veterans' Affairs client', Cancer Epidemiology, 39, pp. 585 - 592
,2014, 'Retrospective studies of end-of-life resource utilization and costs in cancer care using health administrative data: A systematic review', Palliative Medicine, 28, pp. 1167 - 1196, http://dx.doi.org/10.1177/0269216314533813
,2014, 'Retrospective studies of end-of-life resource utilization and costs in cancer care using health administrative data: A systematic review', PALLIATIVE MEDICINE, 28, pp. 1167 - 1196, http://dx.doi.org/10.1177/0269216314533813
,2014, 'Hospitalisations for pelvic inflammatory disease temporally related to a diagnosis of chlamydia or gonorrhoea: A retrospective cohort study', PLoS ONE, 9, pp. e94361, http://dx.doi.org/10.1371/journal.pone.0094361
,2014, 'Minimal excess risk of cancer and reduced risk of death from cancer in Australian Department of Veterans' Affairs clients: A record linkage study', Australian and New Zealand Journal of Public Health, 38, pp. 30 - 34, http://dx.doi.org/10.1111/1753-6405.12168
,2014, 'An audit of cancer of unknown primary notifications: A cautionary tale for population health research using cancer registry data', Cancer Epidemiology, 38, pp. 460 - 464, http://dx.doi.org/10.1016/j.canep.2014.05.004
,2014, 'Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: A randomised controlled trial of specialist vs. non-specialist management', Osteoporosis International, 25, pp. 1345 - 1355, http://dx.doi.org/10.1007/s00198-013-2610-4
,2014, 'Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: A systematic review and critique', European Journal of Health Economics, 15, pp. 93 - 112, http://dx.doi.org/10.1007/s10198-013-0459-2
,2014, 'How well do NSW hospital data identify cases of heart failure?', Medical Journal of Australia, 200, pp. 25, http://dx.doi.org/10.5694/mja13.10207
,2014, 'Inappropriate prescribing in patients accessing specialist palliative day care services', International Journal of Clinical Pharmacy, 36, pp. 535 - 543, http://dx.doi.org/10.1007/s11096-014-9932-y
,2014, 'Optimizing the impact of drugs on symptomburden in older people with multimorbidity at the end of life', JAMA Internal Medicine, 174, pp. 636 - 637, http://dx.doi.org/10.1001/jamainternmed.2013.12875
,2014, 'The use and impact of cancer medicines in routine clinical care: Methods and observations in a cohort of elderly Australians', BMJ Open, 4, pp. e004099, http://dx.doi.org/10.1136/bmjopen-2013-004099
,2013, 'IDENTIFYING EVIDENCE-PRACTICE GAPS IN LUNG CANCER AND PRIORITY SETTING WITH CLINICIANS IN NSW, AUSTRALIA', JOURNAL OF THORACIC ONCOLOGY, 8, pp. S699 - S700, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339624903163&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'A Proxy of Cancer Progression in Dispensing Claims: Validation and Performance', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 22, pp. 221 - 222, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000334876101022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Mifepristone: Increased scope for primary care termination of pregnancy', Medicine Today, 14, pp. 66 - 69
,2013, 'Prescription Drug Use in the Last 12 Months of Life: Observations in a Cohort of Elderly Patients', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 22, pp. 352 - 352, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000334876101270&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'An intragastric balloon in the treatment of obese individuals with metabolic syndrome: A randomized controlled study', Obesity, 21, pp. 1561 - 1570, http://dx.doi.org/10.1002/oby.20414
,2013, 'Erratum: The health services burden of heart failure: An analysis using linked population health data-sets (BMC Health Services Research (2012) 13 (179))', BMC Health Services Research, 13, http://dx.doi.org/10.1186/1472-6963-13-179
,2013, 'Author reply', Internal Medicine Journal, 43, pp. 611 - 611, http://dx.doi.org/10.1111/imj.12131
,2013, 'High risk prescribing in older adults: Prevalence, clinical and economic implications and potential for intervention at the population level', BMC Public Health, 13, http://dx.doi.org/10.1186/1471-2458-13-115
,2013, 'How do medical doctors use a web-based oncology protocol system? A comparison of Australian doctors at different levels of medical training using logfile analysis and an online survey', BMC Medical Informatics and Decision Making, 13, http://dx.doi.org/10.1186/1472-6947-13-82
,2013, 'Uptake of a web-based oncology protocol system: How do cancer clinicians use eviQ Cancer Treatments Online?', BMC Cancer, 13, pp. 112, http://dx.doi.org/10.1186/1471-2407-13-112
,2012, 'A life-cycle approach to monitoring benefits and harms of medicines', Medical Journal of Australia, 197, pp. 313 - 314, http://dx.doi.org/10.5694/mja12.11028
,2012, 'Hospital discharge diagnostic and procedure codes for upper gastro-intestinal cancer: How accurate are they?', BMC Health Services Research, 12, http://dx.doi.org/10.1186/1472-6963-12-331
,2012, 'Improving the quality of oncology guidelines and protocols', Asia-Pacific Journal of Clinical Oncology, 8, pp. 313, http://dx.doi.org/10.1111/j.1743-7563.2012.01570.x
,2012, 'Estimating Disease Progression in Metastatic Cancer Patients Using Dispensing Data: A Validation Study', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 21, pp. 169 - 169, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308131701347&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'The health services burden of heart failure: An analysis using linked population health data-sets', BMC Health Services Research, 12, http://dx.doi.org/10.1186/1472-6963-12-103
,2012, 'Changes in Anticonvulsant Prescribing for Australian Children: Implications for Quality use of medicines', Journal of Paediatrics and Child Health (Vol. 48, Suppl. 2, 2012, 1–13), 48, pp. 490 - 495, http://dx.doi.org/10.1111/j.1440-1754.2011.02223.x
,2012, 'Governance approval for multisite, non-interventional research: What can Harmonisation of Multi-Centre Ethical Review learn from the New South Wales experience?', Internal Medicine Journal, 42, pp. 127 - 131, http://dx.doi.org/10.1111/j.1445-5994.2011.02431.x
,